Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by hmmmmmmmmon Dec 04, 2023 5:55pm
181 Views
Post# 35767948

RE:RE:National Bank

RE:RE:National Bank

It seems quite obvious that we are at .36 cents because the market clearly doesn't believe/ trust management. After years of lofty promises and statements on Dialco- then poof.. 

After years of the similar promises on Tigris- while never hitting their enrollment levels or timelines... 

 

Investors actually want companies that hit their stated goals. And companies that take responsibility and make meaningful changes when they occasionally miss a goal. It seems basic, making excuses and dodging disclosure rarely works in life- especially long term..

 

So while a handful here repeat over and over - they said we are "exceeding expectations", it is guaranteed!  The Market is less naive, it doesn’t just weigh the claim, but also who's making the claim, and their track record for previous claims.

 

Could PMX be worth 2.00? Maybe. But the Market has no interest in taking Management's word for it anymore. To move  the share price Management is going to have to do the thing they have been the worst at - delivering.

 

Maybe raw data at 90 patients (if released) will help the Market regain confidence in the trial and PMX..  until then it is best to find comfort in the .30s and watching Seto stuffing options while twisting himself into knots telling us how great it all is (at the end of the day).

<< Previous
Bullboard Posts
Next >>